The Skin as a Drug Delivery Route

2021 ◽  
pp. 1-30
Author(s):  
Nina Dragićević
Keyword(s):  
2021 ◽  
Vol 12 ◽  
Author(s):  
Haiyang Wu ◽  
Yan Zhou ◽  
Yulin Wang ◽  
Linjian Tong ◽  
Fanchen Wang ◽  
...  

Background: The management of various central nervous system (CNS) disorders has been challenging, due to highly compact blood-brain barrier (BBB) impedes the access of most pharmacological agents to the brain. Among multiple strategies proposed to circumvent this challenge, intranasal delivery route has sparked great interest for brain targeting in the past decades. The aim of this study was to apply scientometric method to estimate the current status and future trends of the field from a holistic perspective.Methods: All relevant publications during 1998–2020 were retrieved from the Web of Science Core Collection (SCIE, 1998-present). Two different scientometric software including VOS viewer and CiteSpace, and one online platform were used to conduct co-authorship, co-citation, and co-occurrence analysis of journals, countries, institutes, authors, references and keywords.Results: A total of 2,928 documents, including 2,456 original articles and 472 reviews, were retrieved. Our analysis revealed a significant increasing trend in the total number of scientific publications over the past 2 decades (R2 = 0.98). The United States dominated the field, reflecting in the largest amount of publications (971), the highest H-index (99), and extensive international collaboration. Jamia Hamdard contributed to most publications. Frey WH and Illum L were key researchers with the highest number of publications and citations, respectively. The International Journal of Pharmaceutics was the most influential academic journal, and Pharmacology/Pharmacy and Neurosciences/Neurology were the hottest research categories in this field. Based on keywords occurrence analysis, four main topics were identified, and the current research focus of this field has shifted from cluster 4 (pathways and mechanisms of intranasal delivery) to cluster 2 (the study of nasal drug delivery systems), especially the nanostructured and nano-sized carrier systems. Keywords burst detection revealed that the research focus on oxidative stress, drug delivery, neuroinflammation, nanostructured lipid carrier, and formulation deserves our continued attention.Conclusion: To the authors’ knowledge, this is the first scientometric analysis regarding intranasal delivery research. This study has demonstrated a comprehensive knowledge map, development landscape and future directions of intranasal delivery research, which provides a practical and valuable reference for scholars and policymakers in this field.


2015 ◽  
Vol 20 (4) ◽  
pp. 491-495 ◽  
Author(s):  
Uma Do J.P. Rai ◽  
Simon A. Young ◽  
Thilini R. Thrimawithana ◽  
Hamdy Abdelkader ◽  
Adam W.G. Alani ◽  
...  

2019 ◽  
Vol 7 (01) ◽  
pp. 05-06
Author(s):  
Navin Banarase

Nasya is one of the most important Panchakarma procedures done in Ayurveda. It is mostly done for the Urdhvajatrugata Vikara. The drug has effects on the Central Nervous System also. Hence it is important to elaborate on the concept of Sharir according to Ayurveda and Modern Medical Science to understand this drug delivery route. Nasya gives the drug mainly gets absorbed by capillaries in the nasal mucosa and also crosses the blood-brain barrier (BBB) as mostly the drug is prepared in the form of Sneha. This article will explain the Sharir concept related to the Nasya procedure.


2015 ◽  
Vol 7 (9) ◽  
pp. 739-745
Author(s):  
R. S. Surenya ◽  
ShantiKumar V. Nair ◽  
Vinoth-Kumar Lakshmanan

2012 ◽  
Vol 6 (2) ◽  
pp. 77-88 ◽  
Author(s):  
A. M. Privalova ◽  
N. V. Gulyaeva ◽  
T. V. Bukreeva

Author(s):  
Jingying Xu ◽  
Jiangang Tao ◽  
Jidong Wang

One of the major reasons why depressed patients fail their treatment course is the existence of the blood-brain barrier (BBB), which prevents drugs from being delivered to the central nervous system (CNS). In recent years, nasal drug delivery has achieved better systemic bioavailability and activity in low doses in antidepressant treatment. In this review, we focused on the latest strategies for delivery carriers (or formation) of intranasal antidepressants. We began this review with an overview of the nasal drug delivery systems, including nasal drug delivery route, absorption mechanism, advantages, and limitations in the nasal drug delivery route. Next, we introduced the development of nasal drug delivery devices, such as powder devices, liquid-based devices, and so on. Finally, intranasal delivery carriers of antidepressants in clinical studies, including nanogels, nanostructured lipid, liposomes nanoparticles, nanoemulsions/microemulsion, were summarized. Moreover, challenges and future perspectives on recent progress of intranasal delivery carriers in antidepressant treatments were discussed.


2021 ◽  
Vol 4 (1) ◽  
Author(s):  
Michael Anthony Huyck ◽  
Sarah Messmer ◽  
Stockton McQuade Mayer ◽  
Charles Yingling

PLoS ONE ◽  
2013 ◽  
Vol 8 (1) ◽  
pp. e55304 ◽  
Author(s):  
Vanina Torres Demichelis ◽  
Aldo A. Vilcaes ◽  
Ramiro Iglesias-Bartolomé ◽  
Fernando M. Ruggiero ◽  
Jose L. Daniotti

Sign in / Sign up

Export Citation Format

Share Document